Intellia is a pre-commercial gene-editing company developing potential once-and-done therapies for serious diseases. Its in vivo gene-editing therapy for hereditary angioedema (HAE) is pending FDA review, and its two global Phase 3 trials in transthyretin (TTR) amyloidosis are underway. The Head of Clinical Development reports to the CMO and serves on the development leadership team, partnering with key stakeholders to define development strategy and oversee clinical development across Intellia’s portfolio, including HAE and TTR. The role provides strategic and medical leadership for clinical development activities across product and pipeline candidates and leads the cross-functional Clinical Development Team. The successful candidate is a physician scientist with hands-on expertise and a collaborative player-coach leadership style, focused on advancing product candidates and delivering life-changing medicines. The role also involves regular presence in the Cambridge, Massachusetts office and approximately 15% domestic and international travel.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree